Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

Nils Venhoff(University Medical Center Freiburg), Jens Thiel(University of Freiburg), Klaus Warnatz(University of Freiburg), Dirk Lebrecht(University Medical Center Freiburg), Michael Schlesier(University Medical Center Freiburg), Ulrich Salzer, Nora M. Effelsberg(University Medical Center Freiburg), Hans Peter(University Medical Center Freiburg), Reinhard Voll(Friedrich-Alexander-Universität Erlangen-Nürnberg)
PLoS ONE
May 21, 2012
10.1371/journal.pone.0037626
Cited by 139

Related Papers

The EUROclass trial: defining subgroups in common variable immunodeficiency
|Blood|2007|860
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency
|Nature Immunology|2003|730
Severe deficiency of switched memory B cells (CD27+IgM−IgD−) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease
|Blood|2002|626
Thalassemia Syndromes
|Unknown|2009|475